Strong Growth Ahead: Pediatric Drugs Market Size To Grow At Arecord 14.9% Cagr By 2029

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Big Is the Pediatric Drugs Market Size Expected to Be by 2034?
The size of the pediatric drugs market has seen swift expansion in the past few years. The market, valued at $157.0 billion in 2024, is projected to reach $181.02 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.3%. Factors contributing to the growth during the historic period include increasing demand for relevant drugs, a large pediatric population, heightened awareness about pediatric diseases, growth in pediatric oncology, the emergence of digital health and telemedicine, and increased cooperation in the development of pediatric drugs.

In the coming years, the pediatric drugs market size is projected to experience speedy expansion. The market is anticipated to rise to $316.0 billion in 2029, with a compound annual growth rate (CAGR) of 14.9%. The escalation during the forecast period can be linked to factors such as a growing pediatric population, an increase in pediatric mental health conditions, a higher number of children living with chronic diseases, an increased vaccination rate amongst children, and escalating demand for pediatric mental health medication. Future trends to look out for during the forecast period comprise bespoke pediatric medicine, the application of technology in pediatric drug distribution, advancements in telemedicine and digital health solutions, improvements in pediatric clinical trials, and heightened collaboration between pediatricians and pharmacists.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249

What Are the Emerging Segments Within the Pediatric Drugs Market?
The pediatric drugs market covered in this report is segmented -

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs
2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids
2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)
3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives
4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

What Long-Term Drivers Are Shaping Pediatric Drugs Market Trends?
Boosting the pediatric drugs market is the rising number of preterm births. Preterm birth denotes the birth of a baby before the 37th week of pregnancy, sooner than the standard 40-week gestation term. Factors such as increased maternal age, lifestyle patterns, multiple pregnancies, health conditions, and insufficient prenatal care contribute to the ballooning number of preterm births. To meet the unique health and development needs of preterm infants such as respiratory issues, infections, and nutritional deficiencies, pediatric drugs play a vital role. For instance, in a 2022 report by Tommy's, a UK-based charity, it was reported that the premature live births in England and Wales had increased to 7.9% in 2022 from 7.5% in 2021. This covers over 53,000 babies prematurely born the same year. Hence, the rise in preterm births is positively impacting the growth of the pediatric drugs market.

Who Are the Top Competitors in Key Pediatric Drugs Market Segments?
Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

What Trends Are Driving Growth in The Pediatric Drugs Market?
Major players in the pediatric drugs market are emphasizing on the development of innovative drugs, like fully human monoclonal antibodies, to enhance treatment success and reduce side effects in pediatric patients. These fully human monoclonal antibodies, generated entirely from human genetic sequences, decrease the possibility of immune responses compared to chimeric or humanized monoclonal antibodies. These antibodies are manufactured using state-of-the-art biotechnological methods, such as transgenic mice embedded with human antibody genes or phage display technology. For example, in August 2022, U.S. pharmaceutical firm Johnson & Johnson garnered FDA approval for its STELARA (ustekinumab) treatment for pediatric patients six years old and above suffering from active psoriatic arthritis (PsA). The approval of STELARA, the first and only biologic drug that targets interleukin-12 (IL-12) and interleukin-23 (IL-23) - crucial cytokines implicated in inflammatory reactions linking to autoimmune diseases - marks a significant breakthrough. Approximately 5-8% of children experiencing chronic inflammatory arthritis, leading to symptoms such as joint inflammation and skin lesions, are reported to have Active PsA.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

Which Regions Are Becoming Hubs for Pediatric Drugs Market Innovation?
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pediatric Drugs Market?
2. What is the CAGR expected in the Pediatric Drugs Market?
3. What Are the Key Innovations Transforming the Pediatric Drugs Industry?
4. Which Region Is Leading the Pediatric Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.